Market Cap
$217,080,606,103
Enterprise Value
$249,214,606,103
Average Volume
$2,051,173
TMO 10-Q Quarter
ended Sept. 27, 2025
THERMO FISHER SCIENTIFIC INC. - TMO
$572.77
-2.47
(-0.43%)
Valuation & Solvency
P/Tangible Book
4.24
P/E
32.95
P/S
4.96
EV/EBITDA
22.40
EV/Sales
5.70
EV/FCF
40.78
Dividend Yield
0.29%
Payout Ratio
9.48%
Total Debt
$35,680,000,000
Cash & Marketable Securities
$3,546,000,000
Quick Ratio
1.11
Debt/Equity
0.70
Net Debt/EBITDA
2.89
Interest Coverage Ratio
5.54
About
Industry
Medical - Diagnostics & Research
Exchange
NYSE
Country
US
Beta
0.90
Company Description
▶
Thermo Fisher Scientific Inc. provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets. Its Analytical Instruments segment provides instruments, consumables, software, and services for pharmaceutical, biotechnology, academic, government, environmental, and other research and industrial markets, as well as clinical laboratories. The company's Specialty Diagnostics segment offers liquid, ready-to-use, and lyophilized immunodiagnostic reagent kits, as well as calibrators, controls, protein detection assays, and instruments; immunodiagnostics develops, manufactures and markets complete bloodtest systems to support the clinical diagnosis and monitoring of allergy, asthma and autoimmune diseases; dehydrated and prepared culture media, collection and transport systems, instrumentation, and consumables; human leukocyte antigen typing and testing for organ transplant market; and healthcare products. Its Laboratory Products and Biopharma Services segment provides laboratory products, research and safety market channel, and pharma services and clinical research. It offers products and services through a direct sales force, customer-service professionals, electronic commerce, and third-party distributors under Thermo Scientific; Applied Biosystems; Invitrogen; Fisher Scientific; Unity Lab Services; and Patheon and PPD. Thermo Fisher Scientific Inc. was founded in 1956 and is headquartered in Waltham, Massachusetts.
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
Directors of THERMO FISHER SCIENTIFIC INC. - as per the latest proxy Beta
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
Subscribe to view this or get a free 24 hour token or take a free test drive with ticker AAPL. View our demo video.
No information found
Customers and Suppliers of THERMO FISHER SCIENTIFIC INC. Beta
Customers
Suppliers
Bonds of THERMO FISHER SCIENTIFIC INC.
Price Graph
Price
Yield
Insider Ownership of THERMO FISHER SCIENTIFIC INC. company Beta
| Owner | Position | Direct Shares | Indirect Shares |
|---|
AI Insights
Summary Financials of THERMO FISHER SCIENTIFIC INC. Beta
(We are using algorithms to extract and display detailed data. This is a hard problem and we are working continuously to classify data in an accurate and useful manner.)
No information found